|
|
 |
 |
Search Results for: S |
 |
|
 |
|
|
 |
| 31 |
(2S,5R)-3,6-Diethoxy-2,5-dihydro-2-[(2S)-2-[[4-methoxy-3-(3 -methoxypropoxy)phenyl]methyl]-3-methylbutyl]-5-(1-methyl ethyl)pyrazine
Manus Aktteva offers Aliskiren hemifumarate Intermediate,(2S,5R)-3,6-Diethoxy-2,5-dihydro-2-[(2S)-2-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-3-methylbutyl]-5-(1-methylethyl)pyrazine, 866030-33-3,for your requirements of RND, evaluation, pilots ....
View Detail
|
 |
|
|
| 32 |
(3S)-3-(tert-Butoxycarbonyl)amino-1-chloro-4-phenyl-2-butanone
Manus Aktteva offers Saquinavir Intermediate, (3S)-3-(tert-Butoxycarbonyl)amino-1-chloro-4-phenyl-2-butanone, having a cas no 102123-74-0, for your requirements of RND, evaluation, pilots and commercials along with supportive technical package requir....
View Detail
|
 |
|
|
| 33 |
(3S,4R)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine
Manus Aktteva offers Paroxetine hydrochloride Intermediates,105812-81-5, (3S,4R)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine,for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 34 |
(4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone
Manus Aktteva offers 189028-93-1, Ezetimibe Intermediate,for your RND, Pilots and commercial requirements with supportive technical package required for evaluation
View Detail
|
 |
|
|
| 35 |
(S)-(+)-3-Chloro-1,2-propanediol
Manus Aktteva offers Rivaroxaban Intermediate, (S)-(+)-3-Chloro-1,2-propanediol, 60827-45-4,for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 36 |
(S)-(+)-N-(2,3-Epoxypropyl)phthalimide
Manus Aktteva offers Rivaroxaban Intermediate, (S)-(+)-N-(2,3-Epoxypropyl)phthalimide, 161596-47-0, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 37 |
(S)-(-)-1,2,3,4-Tetrahedro-naphthoic acid
Manus Aktteva offers Solifenacin Succinate Intermediate,85977-52-2, (S)-(-)-1,2,3,4-Tetrahedro-naphthoic acid, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 38 |
(S)-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine
Manus Aktteva offers Duloxetine intermediate, (S)-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine, 132335-44-5, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 39 |
(S)-1,2,3,4-Tetrahydro-5-methoxy-N-propyl-2-naphthalenamine hydrochloride
Manus Aktteva offers Rotigotine hydrochloride Intermediate, 93601-86-6, (S)-1,2,3,4-Tetrahydro-5-methoxy-N-propyl-2-naphthalenamine hydrochloride, for your evaluation,pilots and commercial requirements with supportive technical package required for e....
View Detail
|
 |
|
|
| 40 |
(S)-1-tert-Butyl 2-ethyl 2,3-dihydro-1H-pyrrole-1,2-dicarboxylate; Ethyl N-Boc-L-proline-4-ene
Manus Aktteva offers Saxagliptin Intermediate,(S)-1-tert-Butyl 2-ethyl 2,3-dihydro-1H-pyrrole-1,2-dicarboxylate; Ethyl N-Boc-L-proline-4-ene, 178172-26-4,for your evaluation,pilots and commercial requirements with supportive technical package require....
View Detail
|
 |
|
|
| 41 |
(S)-2-(Aminomethyl)-1-ethylpyrrolidine
Manus Aktteva offers Levosulpiride intermediate, 22795-99-9, (S)-2-(Aminomethyl)-1-ethylpyrrolidine, for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation for intermediates.
View Detail
|
 |
|
|
| 42 |
(S)-2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine
Manus Aktteva offers Bepotastine besilate intermediate,201594-84-5, (S)-2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine,for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 43 |
(S)-2-Amino-5-methoxytetralin hydrochloride
Manus Aktteva offers Rotigotine hydrochloride Intermediate, 58349-17-0, (S)-2-Amino-5-methoxytetralin hydrochloride, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 44 |
(S)-3-Amino-1,2-propanediol
Manus Aktteva offers Rivaroxaban Intermediate,(S)-3-Amino-1,2-propanediol, 61278-21-5, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 45 |
(S)-3-Aminoquinuclidine dihydrochloride
Manus Aktteva offers 119904-90-4, (S)-3-Aminoquinuclidine dihydrochloride, Solifenacin Succinate Intermediate,for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation for intermed....
View Detail
|
 |
|
|
|
|
|
|
|
 |
NOTE:
- Manus Aktteva, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
- Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Product enquiries may please be sent to info@manusaktteva.in, udeetjbanker@gmail.com, jdbanker@gmail.com
PATENTS:
- => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
=> Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
|
|
|
|
|